Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.

Bader JC, Lakota EA, Dale GE, Sader HS, Rex JH, Ambrose PG, Bhavnani SM.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00318-19. doi: 10.1128/AAC.00318-19. Print 2019 Jun.

PMID:
30962339
2.

Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia.

Bhavnani SM, Zhang L, Hammel JP, Rubino CM, Bader JC, Sader HS, Gelone SP, Wicha WW, Ambrose PG.

J Antimicrob Chemother. 2019 Apr 1;74(Supplement_3):iii35-iii41. doi: 10.1093/jac/dkz089.

3.

Time for Precision: A World Without Susceptibility Breakpoints.

Bader JC, Lakota EA, Andes DR, Rubino CM, Ambrose PG, Bhavnani SM.

Open Forum Infect Dis. 2018 Oct 31;5(12):ofy282. doi: 10.1093/ofid/ofy282. eCollection 2018 Dec.

4.

Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae.

Lepak AJ, Zhao M, Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02404-18. doi: 10.1128/AAC.02404-18. Print 2019 Mar.

PMID:
30559140
5.

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.

Bader JC, Lakota EA, Flanagan S, Ong V, Sandison T, Rubino CM, Bhavnani SM, Ambrose PG.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02614-17. doi: 10.1128/AAC.02614-17. Print 2018 Jun.

6.

Correction to: PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside.

Bulik CC, Bader JC, Zhang L, Van Wart SA, Rubino CM, Bhavnani SM, Sweeney KL, Ambrose PG.

J Pharmacokinet Pharmacodyn. 2018 Apr;45(2):351. doi: 10.1007/s10928-018-9572-2.

PMID:
29446052
7.

Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity.

Ambrose PG, VanScoy BD, Adams J, Fikes S, Bader JC, Bhavnani SM, Rubino CM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02257-17. doi: 10.1128/AAC.02257-17. Print 2018 Apr.

8.

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.

Zhao M, Lepak AJ, VanScoy B, Bader JC, Marchillo K, Vanhecker J, Ambrose PG, Andes DR.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02542-17. doi: 10.1128/AAC.02542-17. Print 2018 Apr.

9.

We can do better: a fresh look at echinocandin dosing.

Bader JC, Bhavnani SM, Andes DR, Ambrose PG.

J Antimicrob Chemother. 2018 Mar 1;73(3):831. doi: 10.1093/jac/dky013. No abstract available.

PMID:
29340605
10.

We can do better: a fresh look at echinocandin dosing.

Bader JC, Bhavnani SM, Andes DR, Ambrose PG.

J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i44-i50. doi: 10.1093/jac/dkx448. Review. Erratum in: J Antimicrob Chemother. 2018 Mar 1;73(3):831.

PMID:
29304211
11.

Ensuring quality pharmacokinetic analyses in antimicrobial drug development programs.

Lakota EA, Bader JC, Rubino CM.

Curr Opin Pharmacol. 2017 Oct;36:139-145. doi: 10.1016/j.coph.2017.10.014. Epub 2017 Nov 20. Review.

PMID:
29156443
12.

Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters.

Lakota EA, Bader JC, Ong V, Bartizal K, Miesel L, Andes DR, Bhavnani SM, Rubino CM, Ambrose PG, Lepak AJ.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00758-17. doi: 10.1128/AAC.00758-17. Print 2017 Nov.

13.

PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside.

Bulik CC, Bader JC, Zhang L, Van Wart SA, Rubino CM, Bhavnani SM, Sweeney KL, Ambrose PG.

J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):161-177. doi: 10.1007/s10928-017-9518-0. Epub 2017 Mar 28. Erratum in: J Pharmacokinet Pharmacodyn. 2018 Feb 14;:.

PMID:
28353185
14.

[Treatment of obesity in children and its results].

Borniche P, Bader JC.

Rev Prat. 1980 May 11;30(27):1825-33. French. No abstract available.

PMID:
7455546
15.

[Cryptorchism and its treatment].

Bader JC, Canlorbe P.

Rev Prat. 1977 Mar 11;27(15):949-52, 957-60, 963-4. French. No abstract available.

PMID:
15310
16.

[Cryptorchism].

Canlorbe P, Borniche P, Bader JC, Vassal J, Toublanc JE, Job JC.

Arch Fr Pediatr. 1974 Feb-Mar;31(2):145-56. French. No abstract available.

PMID:
4152654
17.

[Treatment of pituitary dwarfism with synthetic anabolic drugs].

Canlorbe P, Job JC, Bader JC, Borniche P, Roger M, Peigné A.

Ann Pediatr (Paris). 1972 Dec 2;19(12):839-51. French. No abstract available.

PMID:
4646740
18.

[Diagnostic problems raised by a malignant virilizing tumor of the adrenal cortex (on a case Review of the literature)].

Canlorbe P, Bader JC, Job JC.

Ann Pediatr (Paris). 1971 Oct 14;18(10):593-608. French. No abstract available.

PMID:
5126453
19.

[Parathyroid adenomas in children treated surgically].

Canlorbe P, Lagrue G, Bader JC.

Ann Pediatr (Paris). 1969 Oct 2;16(10):573-81. French. No abstract available.

PMID:
5357396
20.

[Treatment of pituitary dwarfism with synthetic anabolic drugs].

Canlorbe P, Borniche P, Job JC, Bader JC.

Ann Pediatr (Paris). 1969 Oct 2;16(10):590-602. French. No abstract available.

PMID:
4311469
21.

[Effect of 2 anabolic steroids on "essential" delayed growth].

Canlorbe P, Borniche P, Bader JC.

Ann Pediatr (Paris). 1969 Oct 2;16(10):582-9. French. No abstract available.

PMID:
4311468
22.

[Hyperthyroidism in children].

Bader JC.

Cah Coll Med Hop Paris. 1968 Dec 31;9(14):1133-40. French. No abstract available.

PMID:
5757608
23.

[Treatment of idiopathic hypercalcemia].

Bader JC.

Presse Med. 1968 Nov 30;76(47):2223-6. French. No abstract available.

PMID:
4976080
24.

[Albright's hereditary osteodystrophy. 3 new cases with thyrocalcitonin and calcium 45 tests].

Bader JC, Canlorbe P, Lambertz J, Poitout M, Lelong M.

Ann Pediatr (Paris). 1968 Apr 2;15(4):1061-73. French. No abstract available.

PMID:
5743017
25.

[Familial hypoparathyroidism syndrome with hypercalciuria].

Lelong M, Canlorbe P, Lagrue G, Bader JC.

Ann Pediatr (Paris). 1968 Apr 2;15(4):1045-60. French. No abstract available.

PMID:
5743016
26.

[Treatment of excessive height in the young girl].

Bader JC.

Cah Coll Med Hop Paris. 1966 Feb;7(2):97-101. French. No abstract available.

PMID:
5931859
27.

[Discovery of a familial hypercholesteremia of xanthomatous origin on the occasion of etiologic exploration of a recently appeared deafness in a 9-year-old child].

Bader JC, Canlorbe P, de Gennes JL.

Bull Mem Soc Med Hop Paris. 1965 Oct 29;116(13):Suppl:1273-84. French. No abstract available.

PMID:
4955377
28.

[The new drugs in pediatrics].

Bader JC.

Presse Therm Clim. 1965;102(3):172-6. French. No abstract available.

PMID:
5897402
29.

[A new hepato-biliary stimulant in pediatrics].

Bader JC.

Sem Ther. 1964 Nov;40(9):541-4. French. No abstract available.

PMID:
5878665
30.

[SEX DETERMINATION AT BIRTH].

BADER JC.

Maternite. 1964 Jan-Feb;13:5-14. French. No abstract available.

PMID:
14135737
31.

[Photogenic epilepsy with intermittent auto-stimulation].

LELONG M, HABIB EC, KREISLER L, BADER JC, DELARUE R.

Arch Fr Pediatr. 1961 Feb;18:163-81. French. No abstract available.

PMID:
13760689

Supplemental Content

Loading ...
Support Center